Lattice Biologics (TSXV:LBL.H) Days Sales Outstanding : 0.00 (As of Jun. 2021)

View and export this data going back to 1995. Start your Free Trial

What is Lattice Biologics Days Sales Outstanding?

Lattice Biologics's average Accounts Receivable for the three months ended in Jun. 2021 was C$0.00 Mil. Lattice Biologics's Revenue for the three months ended in Jun. 2021 was C$0.00 Mil.

The historical rank and industry rank for Lattice Biologics's Days Sales Outstanding or its related term are showing as below:

TSXV:LBL.H's Days Sales Outstanding is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 65.13
* Ranked among companies with meaningful Days Sales Outstanding only.

Lattice Biologics's Days Sales Outstanding declined from Jun. 2020 (52.17) to Jun. 2021 (0.00).

Lattice Biologics Days Sales Outstanding Historical Data

The historical data trend for Lattice Biologics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lattice Biologics Days Sales Outstanding Chart

Lattice Biologics Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Sep16

Sep17

Sep18

Sep19

Sep20

Days Sales Outstanding

Get a 7-Day Free Trial

20.67

44.61

59.30

36.08

41.09

Lattice Biologics Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Days Sales Outstanding	Get a 7-Day Free Trial															52.17	37.65	45.93	57.47	-

Competitive Comparison of Lattice Biologics's Days Sales Outstanding

For the Medical Devices subindustry, Lattice Biologics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lattice Biologics's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lattice Biologics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Lattice Biologics's Days Sales Outstanding falls into.

Lattice Biologics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Lattice Biologics's Days Sales Outstanding for the fiscal year that ended in Sep. 2020 is calculated as

	Days Sales Outstanding (A: Sep. 2020 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2019 )	+	Accounts Receivable (A: Sep. 2020 ))	/	count )	/	Revenue (A: Sep. 2020 )	*	Days in Period
=	( (0.35	+	0.384)	/	2 )	/	3.26	*	365
=	0.367					/	3.26	*	365
=	41.09

Lattice Biologics's Days Sales Outstanding for the quarter that ended in Jun. 2021 is calculated as:

	Days Sales Outstanding (Q: Jun. 2021 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2021 )	+	Accounts Receivable (A: Jun. 2021 ))	/	count )	/	Revenue (A: Jun. 2021 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Lattice Biologics (TSXV:LBL.H) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Lattice Biologics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Lattice Biologics (TSXV:LBL.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lattice Biologics Ltd (TSXV:LBL.H) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714

Website

http://www.latticebiologics.com

Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.

Lattice Biologics (TSXV:LBL.H) Headlines

No Headlines